𝗖𝗦 𝗩𝗲𝗻𝘁𝘂𝗿𝗲 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗙𝘂𝗻𝗱, 𝗟.𝗣. was founded by 𝗥𝘂𝘀𝘀𝗲𝗹𝗹 𝗖𝗮𝗿𝘀𝗼𝗻 (founder of the private equity firm Welsh, Carson, Anderson & Stowe) and 𝗤𝘂𝗶𝗻𝘁𝗲𝗻 𝗦𝘁𝗲𝘃𝗲𝗻𝘀 in March 2022. The fund is focused on early-stage companies. The strategy is to invest in compelling and potentially disruptive technologies sourced from brilliant scientists, at top US research universities. Investments are made across a range of industries including advanced medical and industrial technology, life sciences and software. CS Venture has invested in the following companies:𝗔𝗺𝗼𝗿𝗽𝗵𝗼𝗹𝗼𝗴𝘆 has revolutionized metal manufacturing using bulk metal glasses, with high precision gears cast in minutes 𝐚𝐧𝐝𝐫𝐨𝐬 offers healthcare credentialing, monitoring and provider network management𝗔𝗽𝗽𝗹𝗮𝘂𝗱 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 has developed a transformative kidney stone treatment process𝐁𝐞𝐡𝐚𝐯𝐢𝐨𝐫𝐚𝐥 𝐒𝐢𝐠𝐧𝐚𝐥𝐬 has AI technology that uses tonal voice analytics to determine human intention𝐅𝐥𝐚𝐬𝐡𝐩𝐨𝐢𝐧𝐭 is transforming therapeutic components through optimized nanoscale architecture 𝗚𝘂𝗥𝘂 𝗪𝗶𝗿𝗲𝗹𝗲𝘀𝘀 has compelling wireless power technology which can power devices over the airwaves𝗠𝗮𝘁𝘁𝗶𝗾 is creating a massive library of new materials which can be analyzed using AI and ML𝗡𝗩𝗮𝘀𝗰 has developed a compound that has the potential to cure blindness𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 has developed a SaaS program that captures a broad range of patient insights that will advance health care equity𝗣𝘁𝗲𝗿𝗼𝗗𝘆𝗻𝗮𝗺𝗶𝗰𝘀 has developed a VTOL drone that uses their unique Transwing™ design to perform helicopter take offs and landings and then fixed wing flight between destinations𝗦𝗽𝗲𝗰𝘁𝗲𝗿 𝗔𝗲𝗿𝗼𝘀𝗽𝗮𝗰𝗲 is developing plasma ignition systems for hypersonic engines𝗩𝗶𝘃𝗼𝗱𝘆𝗻𝗲 has developed a fully automated robotic system allowing experimentation on thousands of lab-grown human tissues with powerful AI and ML

Equipment Financing/Commercial Lending

Investment Banking - Equity Capital Markets